CARL ZEISS MEDITEC ADR 1 (F:AFXA) — Stock Price
CARL ZEISS MEDITEC ADR 1 (F:AFXA) is currently trading at €26.60 EUR, down 1.48% today. Over the past 52 weeks, shares have ranged between €22.40 and €65.00. This page tracks CARL ZEISS MEDITEC ADR 1's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of CARL ZEISS MEDITEC ADR 1.
CARL ZEISS MEDITEC ADR 1 (AFXA) Stock Price Chart — Daily History & Trading Volume
The chart below tracks CARL ZEISS MEDITEC ADR 1's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
CARL ZEISS MEDITEC ADR 1 Income Statement — Revenue, Profit & Earnings by Year
CARL ZEISS MEDITEC ADR 1's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | €2.23 Billion | €2.07 Billion | €2.09 Billion | €1.90 Billion |
| Cost of Revenue | €1.05 Billion | €977.50 Million | €883.53 Million | €775.24 Million |
| Gross Profit | €1.18 Billion | €1.09 Billion | €1.21 Billion | €1.13 Billion |
| Research & Development | €326.27 Million | €343.09 Million | €349.28 Million | €291.37 Million |
| SG&A | €626.52 Million | €569.21 Million | €504.06 Million | €438.06 Million |
| Total Operating Expenses | €2.00 Billion | €1.87 Billion | €1.74 Billion | €1.51 Billion |
| Operating Income | €223.32 Million | €194.45 Million | €348.12 Million | €396.88 Million |
| EBITDA | — | — | — | — |
| EBIT | — | — | — | — |
| Interest Expense | €26.62 Million | €29.42 Million | €15.25 Million | €9.59 Million |
| Income Before Tax | €193.89 Million | €240.87 Million | €412.56 Million | €403.49 Million |
| Income Tax Expense | — | — | — | — |
| Net Income | €141.21 Million | €178.73 Million | €290.40 Million | €293.91 Million |
CARL ZEISS MEDITEC ADR 1 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes CARL ZEISS MEDITEC ADR 1's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Assets | €3.40 Billion | €3.39 Billion | €3.03 Billion | €2.82 Billion |
| Total Current Assets | €1.27 Billion | €1.21 Billion | €1.91 Billion | €1.79 Billion |
| Cash & Equivalents | — | — | — | — |
| Short-term Investments | — | — | — | — |
| Net Receivables | €209.01 Million | €209.05 Million | €196.92 Million | €197.80 Million |
| Inventory | €496.98 Million | €536.16 Million | €519.62 Million | €382.75 Million |
| Property, Plant & Equipment | — | — | — | — |
| Goodwill | €969.74 Million | €982.50 Million | €415.78 Million | €429.65 Million |
| Total Liabilities | €1.28 Billion | €1.34 Billion | €860.02 Million | €792.73 Million |
| Total Current Liabilities | €543.81 Million | €568.84 Million | €561.65 Million | €539.32 Million |
| Long-term Debt | — | — | — | — |
| Net Debt | — | — | — | — |
| Total Stockholder Equity | €2.12 Billion | €2.04 Billion | €2.16 Billion | €2.02 Billion |
| Retained Earnings | €1.58 Billion | €1.49 Billion | €1.41 Billion | €1.21 Billion |
CARL ZEISS MEDITEC ADR 1 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how CARL ZEISS MEDITEC ADR 1 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Cash Flow | €209.86 Million | €247.32 Million | €250.86 Million | €188.20 Million |
| Capital Expenditures | €76.59 Million | €152.20 Million | €113.86 Million | €81.97 Million |
| Free Cash Flow | €133.26 Million | €95.11 Million | €137.00 Million | €106.23 Million |
| Investing Cash Flow | — | — | — | — |
| Financing Cash Flow | — | — | — | — |
| Dividends Paid | €-52.52 Million | €98.20 Million | €98.39 Million | €80.50 Million |
| Stock-Based Compensation | — | — | — | — |
| Depreciation | €126.38 Million | €132.77 Million | €74.06 Million | €69.77 Million |
| Change in Cash | €6.98 Million | €9.68 Million | €2.87 Million | €290.00K |
CARL ZEISS MEDITEC ADR 1 Earnings History — EPS Actual vs. Analyst Estimates
Track CARL ZEISS MEDITEC ADR 1's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 11, 2026 | — | — | — |
| Feb 10, 2026 | — | — | — |
| May 06, 2025 | — | — | — |
| Feb 07, 2025 | — | — | — |